[Vaccination of the very premature infant].
Lequien
P
P
Hôpital Jeanne-de-Flandre, CHRU, 59037 Lille, France. plequien@chru-lille.fr
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000008:administration & dosage; D006801:Humans; D007107:Immune System / Q000254:growth & development; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D000069455:Palivizumab; D012307:Risk Factors; D014611:Vaccination / Q000009:adverse effects
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab